These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24291656)

  • 1. Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis.
    Aslibekyan S; Sha J; Redden DT; Moreland LW; O'Dell JR; Curtis JR; Mikuls TR; Reynolds RJ; Danila MI; Bridges SL
    Ann Rheum Dis; 2014 Apr; 73(4):785-6. PubMed ID: 24291656
    [No Abstract]   [Full Text] [Related]  

  • 2. Differing effects of methylenetetrahydrofolate reductase single nucleotide polymorphisms on methotrexate efficacy and toxicity in rheumatoid arthritis.
    Evans WE
    Pharmacogenetics; 2002 Apr; 12(3):181-2. PubMed ID: 11927832
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis.
    Sandhu A; Dhir V; Ahmad S; Dhawan V; Kaur J; Bhatnagar A
    Clin Rheumatol; 2020 Jan; 39(1):201-206. PubMed ID: 31522319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of methotrexate in rheumatoid arthritis: does race make a difference?
    Dervieux T
    J Rheumatol; 2008 Apr; 35(4):550-2. PubMed ID: 18398948
    [No Abstract]   [Full Text] [Related]  

  • 5. MTHFR polymorphisms, C677T and A1298C, are not a genetic risk factor for liver stiffness index in methotrexate-treated rheumatoid arthritis patients.
    Choe JY; Park SH; Kim SK
    Clin Exp Rheumatol; 2011; 29(1):144-5. PubMed ID: 21269580
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses.
    Urano W; Taniguchi A; Yamanaka H; Tanaka E; Nakajima H; Matsuda Y; Akama H; Kitamura Y; Kamatani N
    Pharmacogenetics; 2002 Apr; 12(3):183-90. PubMed ID: 11927833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis?
    Ranganathan P; Eisen S; Yokoyama WM; McLeod HL
    Ann Rheum Dis; 2003 Jan; 62(1):4-9. PubMed ID: 12480661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
    Berkun Y; Levartovsky D; Rubinow A; Orbach H; Aamar S; Grenader T; Abou Atta I; Mevorach D; Friedman G; Ben-Yehuda A
    Ann Rheum Dis; 2004 Oct; 63(10):1227-31. PubMed ID: 15361376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
    Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS
    Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-gene interactions in folate and adenosine biosynthesis pathways affect methotrexate efficacy and tolerability in rheumatoid arthritis.
    Dervieux T; Wessels JA; van der Straaten T; Penrod N; Moore JH; Guchelaar HJ; Kremer JM
    Pharmacogenet Genomics; 2009 Dec; 19(12):935-44. PubMed ID: 19858780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate related adverse effects in patients with RA.
    Ranganathan P
    Ann Rheum Dis; 2005 Jun; 64(6):968; author reply 968. PubMed ID: 15897319
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis.
    Jekic B; Maksimovic N; Damnjanovic T
    Pharmacogenomics; 2019 Nov; 20(17):1235-1245. PubMed ID: 31648623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rheumatoid arthritis and polycythemia vera JAK2 negative association: Polycythemia may be worsening under methotrexate?].
    Saidane O; Sellami M; Mahmoud I; Ben Tekaya A; Tekaya R; Abdelmoula L
    Therapie; 2018 Sep; 73(4):351-353. PubMed ID: 29373131
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.
    Owen SA; Lunt M; Hider SL; Bruce IN; Barton A; Thomson W
    Arthritis Rheum; 2010 Dec; 62(12):3827-9. PubMed ID: 20848569
    [No Abstract]   [Full Text] [Related]  

  • 19. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.
    Tian H; Cronstein BN
    Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update.
    Ling SF; Bluett J
    Pharmacogenomics; 2020 Jan; 21(1):3-6. PubMed ID: 31849277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.